Modafinil treatment of fatigue in patients with ALS: A placebo-controlled study

Muscle and Nerve

Volumn 39, Issue 3, 2009, Pages 297-303

  Rabkin, Judith G ^a,b   Gordon, Paul H ^c   Mcelhiney, Martin ^b   Rabkin, Richard ^b   Chew, Sheena ^d   Mitsumoto, Hiroshi ^a,d  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

ALS; Clinical trial; Fatigue; Modafinil

Indexed keywords

MODAFINIL; PLACEBO;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; EPWORTH SLEEPINESS SCALE; FATIGUE; FEMALE; FOLLOW UP; HUMAN; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 62849083840     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21245     Document Type: Article

References (29)

1. Adler CH, Cavinoss JN, Hentz JG, Lind M, Tiede J. Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease. Mov Disord 2003;18:287-293.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association; 1994.
3. Beck AT, Steer R, Brown G. Manual for Beck Depression Inventory-II. San Antonio, TX: Psychological Corp.; 1996.
4. Carter G, Weiss M, Lou JS, Jensen M, Abresch R, Martin T, et al. Modafinil to treat fatigue in amyotrophic lateral sclerosis: an open label pilot study. Am J Hosp Palliat Care 2005;22:55-59.
5. Cederbaum J, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS Functional Rating Scale that incorporates assessments of respiratory function. J Neurol Sci 1999;169:13-21.
6. Chan KM, Strohschein F, Rydz D, Allidina A, Shuaib A, Westbury C. Randomized controlled trial of modafinil for the treatment of fatigue in postpolio patients. Muscle Nerve 2006;33:138-141.
7. Damian MS, Gorlach A, Schmidt F, Lehmann E, Reichmann H. Modafinil for excessive daytime sleepiness in myotonic dystrophy. Neurology 2001;56:794-796.
8. Del Bene M, Albert S, Brandis M, Mitsumoto H. Can death be predicted in ALS? Amyotroph Other Motor Neuron Dis 2003;4(Suppl 1):40.
9. First M, Spitzer R, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID I/P, version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute; 1996
10. Forshew D, Bromberg M. A survey of clinicians' practice in the symptomatic treatment of ALS. ALS Other Motor Neuron Dis 2003;4:258-263.
11. Ganzini L, Johnson W, McFarland B, Tolle S, Lee M. Attitudes of patients with amyotrophic lateral sclerosis and their caregivers toward assisted suicide. N Engl J Med 1998;339:967-973.
12. Jackson C, Rosenfeld J. Symptomatic pharmacotherapy: Bulbar and constitutional symptoms. In: Mitsumoto H, Przedborski S, Gordon P, editors. Amyotrophic lateral sclerosis. New York: Taylor & Francis; 2006. p 649-664.
13. Johns M. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991;14:540-545.
14. Kos D, Duportail M, D'hooghe M, Nagels G, Kerckhofs E. Multidisciplinary fatigue management programme in multiple sclerosis: a randomized clinical trial. Mult Scler 2007;13:996-1003.
15. Krupp L, LaRocca N, Muir-Nash J, Steinberg A. The Fatigue Severity Scale. Arch Neurol 1989;46:1121-1123.
16. Lou JS, Reeves A, Benice T, Sexton G. Fatigue and depression are associated with poor quality of life in ALS. Neurology 2003;60:122-123.
17. Miller RG. Role of fatigue in limiting physical activities in humans with neuromuscular diseases. Am J Phys Med Rehabil 2002;81(Suppl):S99-S107.
18. Minzenberg M, Carter C. Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology 2008;33:1477-1502.
19. Norris F, Tan Y, Fallat R, Elias L. Trial of oral physostigmine in amyotrophic lateral sclerosis. Clin Pharmacol Ther 1993;54:680-682.
20. Ondo WG, Fayle R, Atassi F, Jankovic J. Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial. J Neurol Neurosurg Psychiatry 2005;76:1636-1639.
21. Rabkin JG, Markowitz J, Ocepek-Welikson K. General vs systematic inquiry about treatment emergent clinical events with SAFTEE: implications for clinical research. J Clin Psychopharmacol 1992;12:3-10.
22. Rabkin JG, McElhiney M, Rabkin R, Ferrando S. Modafinil treatment for fatigue in HIV+ patients: a pilot study. J Clin Psychiatry 2004;65:1688-1695.
23. Rabkin JG, Albert S, Del Bene M, O'Sullivan I, Tider T, Rowland L, et al. Prevalence of depressive disorders and change over time in late-stage ALS. Neurology 2005;65:62-67.
24. Rammohan K, Rosenberg J, Lynn D, Blumenfeld A, Pollak C, Nagaraja H. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatry 2002;72:179-183.
25. Rush AJ, First M, Blacker D (eds.). Handbook of Psychiatric Measures, 2nd ed. Washington, DC: American Psychiatric Publishing; 2008.
26. Sanjack M, Brinkmann J, Beldon D, Roelke K, Waclawik A, Neville H, et al. Quantitative assessment of motor fatigue in amyotrophic lateral sclerosis. J Neurol Sci 2001;191:55-59.
27. Sharma K, Kent-Braun J, Majumdar S, Huang Y, Mynhier M, Weiner M, et al. Physiology of fatigue in amyotrophic lateral sclerosis. Neurology 1995;45:733-740.
28. Spitzer R, Kroenke K, Williams J. Validation and utility of a self-report version of PRIME-MD: the PHQ Primary Care Study. JAMA 1999;282:1737-1744.
29. Vasconcelos OM, Prokhorenko O, Salajegheh M, Kelley K, Livornese K, Olsen C, et al. Modafinil for treatment of fatigue in post-polio syndrome: A randomized controlled trial. Neurology 2007;68:1680-1686.